IAM
ALXN
Iridian Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-656,409
| Closed | -$103M | – | 119 |
|
|
2020
Q4 | $103M | Sell |
656,409
-779,855
| -54% | -$122M | 1.87% | 26 |
|
|
2020
Q3 | $164M | Sell |
1,436,264
-78,610
| -5% | -$9M | 3.59% | 8 |
|
|
2020
Q2 | $170M | Sell |
1,514,874
-460,317
| -23% | -$51.7M | 3.75% | 5 |
|
|
2020
Q1 | $177M | Buy |
1,975,191
+254,940
| +15% | +$22.9M | 4.29% | 3 |
|
|
2019
Q4 | $186M | Sell |
1,720,251
-54,099
| -3% | -$5.85M | 3.05% | 10 |
|
|
2019
Q3 | $174M | Sell |
1,774,350
-9,929
| -0.6% | -$972K | 2.72% | 14 |
|
|
2019
Q2 | $234M | Sell |
1,784,279
-404,644
| -18% | -$53M | 3.38% | 4 |
|
|
2019
Q1 | $296M | Sell |
2,188,923
-306,024
| -12% | -$41.4M | 3.77% | 4 |
|
|
2018
Q4 | $243M | Buy |
2,494,947
+129,869
| +5% | +$12.6M | 3.26% | 7 |
|
|
2018
Q3 | $329M | Buy |
2,365,078
+868,886
| +58% | +$121M | 3.29% | 8 |
|
|
2018
Q2 | $186M | Buy |
1,496,192
+1,486,251
| +14,951% | +$185M | 1.72% | 28 |
|
|
2018
Q1 | $1.11M | Buy |
+9,941
| New | +$1.11M | 0.01% | 65 |
|